Monday, December 4, 2017

A mystery trader keeps betting that the stock market will go crazy

A mystery trader keeps betting that the stock market will go crazy

  • A trader just rolled over a massive volatility bet that could pay out $260 million if all goes according to plan.
  • The wager is on a large increase in the VIX, which serves as the stock market's fear gauge and has been sitting near record-low levels for months.


The market's foremost volatility bull is at it yet again.
Just over two months after rolling over a humongous wager that the CBOE Volatility Index, or VIX, would surge from its subdued levels by December, the volatility vigilante has essentially extended that bet into January.
The so-called rollover carries roughly the same maximum potential payout as before: a whopping $260 million.
And considering the trader lost only a small fraction of that on the wager over the past two months, closing the December trade and pushing it to January allows continued exposure to a huge upside at a relatively small cost, according to a person familiar with the trade.
Considering the VIX's tendency in 2017 to trade near all-time lows, it's a risky bet. The so-called fear gauge is down 7.7% this year, and investors continue to pile into the short-volatility trade, which has evolved into one of the market's most crowded positions.
Still, some volatility has returned to the market in recent days, with uncertainty around the White House's Russia investigation sending the VIX 16% higher on Friday alone.
Let's unpack the trade:
  • To fund it, the investor sold approximately 260,000 VIX puts expiring in January with a strike price of 12.
  • The trader then used those proceeds to buy a VIX 1x2 call spread, which involves buying 260,000 VIX January calls with a strike price of 15 and selling 520,000 VIX January calls with a strike price of 25.
  • Bullish call spreads are used when a moderate rise in the underlying asset is expected. Traders buy call options at a specific strike price while selling the same number of calls of the same asset and expiration date at a higher strike.
  • In a perfect scenario, in which the VIX hits but doesn't exceed 25 before the December expiration, the trader would see a $260 million payout.
  • It is possible for the VIX to spike too much. If it increased beyond 35, the investor would start to lose money since the person used a call spread, even though the direction of the trade was correct.
  • For context, VIX January futures are trading at 13.57, while the spot traded at 13.09 as of 12:51 p.m. on Friday.
  • All data is from Bloomberg and was reviewed by a person familiar with the trade.
There are a couple of potential explanations for the trade. The first is that the trader decided the prolonged low-volatility environment would end in the next couple of months. While it seems as though it could stretch on forever, even the longest stretches of subdued price swings have eventually given way to fluctuations.
It's also possible the investor is betting on volatility around some key events. The trade's December expiration will capture a Federal Reserve meeting as well as a deadline for the government's debt-ceiling decision. There's a 96% chance the central bank will increase its benchmark interest rate by 25 basis points at the December meeting, according to Bloomberg's World Interest Rate Probability data.
While this mystery trader is making waves with large bets, the person is not alone in wagering on a VIX spike. The trader known as 50 Cent — recently revealed to be affiliated with Ruffer LLP, a $20 billion investment fund based in London — rose to prominence with repeated bite-size volatility bets.
If Friday's whipsawing market action is any indication, this brave proponent of stock chaos may final be able to cash in on an elevated volatility regime. If not, the odds are that the person will extend the trade once again.
And can you blame the person? There's a $260 million payout at stake.

CVS Health is buying Aetna for $69 billion in 2017's biggest deal

CVS Health is buying Aetna for $69 billion in 2017's biggest deal

CVS Health CEOCVS Health President and CEO Larry J. Merlo Reuters
  • CVS Health is buying Aetna for $69 billion ($145 a share and 0.8378 CVS shares per Aetna share).
  • The deal that was rumored for months was finally announced on Sunday.
  • The merger could reshape the American health care system as we know it.


CVS Health is buying Aetna, the companies announced Sunday.
The pharmacy giant is acquiring the third largest US insurer in a $69 billion deal. Aetna stockholders will be paid $145 a share in cash and 0.8378 CVS shares per Aetna share.
The deal creates a new type of company that includes a health insurer, a retail pharmacy, and a company that negotiates prescription drug prices with drugmakers called a pharmacy benefits manager. It's the biggest merger to happen in the US in 2017.
"This is a natural evolution for both companies as they seek to put the consumer at the center of health care delivery," the companies said in a news release. 
The timing of this massive acquisition is no coincidence. Speculation that Amazon might be getting into the pharmacy business has been rampant for months, and the company's notorious for stepping into new businesses and crushing the competition with low prices, fast delivery, and its massive network of loyal shoppers.

What this means for how your medication gets paid for

With the Aetna deal, CVS wouldn't be alone in controlling both the insurer and PBM part of paying for prescriptions. UnitedHealthcare, for example, owns the PBM OptumRx, while Anthem, which owns a variety of Blue Cross Blue Shield health insurance firms, will be launching its own PBM called IngenioRx.
Essentially, CVS would own every step of the prescription drug process with the exception of drug wholesalers, which are in charge of shipping drugs to pharmacies and hospitals, and the pharmaceutical companies that actually make the drugs. That would keep much of the money changing hands within the same company.
Here's a chart explaining how a drug travels from pharmaceutical manufacturer to a patient, and who takes a cut in the process. It's a complicated web of payments and rebates, but the simplified outcome of a deal that puts pharmacy, insurer, and PBM in one company is that the combined business walks away with more of a drug's sale price in the end.

With the Aetna deal, CVS would control everything that happens once a wholesaler has handed off the drug.
Who pays for your medication pharmaSkye Gould/Business Insider

Global market cap is about to hit $100 trillion and Goldman Sachs thinks the only way is down

Global market cap is about to hit $100 trillion and Goldman Sachs thinks the only way is down

  • Global market cap is about to hit $100 trillion.
  • A bull run of this length — nearly nine years — was last seen before the Great Depression.
  • Goldman Sachs believes the "bull market in everything" is about to come to an end.
  • In the medium term, we face either "slow pain" or "fast pain" in the equities markets, Goldman says.


This is a chart of the value of all stocks in all companies in all countries, globally. It is, technically, the market cap of Planet Earth, and everyone who sees it does a double take. In just the last few months, total market cap has rocketed upward to nearly $100 trillion worldwide:
world market capBusiness Insider / Bloomberg data
We first saw the chart in a note from CLSA analyst Damian Kestel: "I almost fell off my chair when I saw this and went to check that Bloomberg hadn’t reclassified some data … but no. I included this chart of total equity market cap in [a previous note to clients] in early June this year. At that point total world market cap was US$74 trillion, it’s now US$93 trillion," he wrote. (The chart excludes ETFs and the like, so there is no double-counting of single stocks in different indexes.)
What is worrying about the chart is that final, fast peak in 2017. Until then, world market cap looked like any other stock index: A series of incremental gains building on each other over time, with a pronounced dip around the Great Financial Crisis in 2008, followed by a healthy recovery.
This year, the chart just looks insane.

In the medium term there will be either "slow pain" or "fast pain"

Goldman Sachs international analyst Christian Mueller-Glissmann and his colleagues think the "bull market in everything" is about to come to an end. "the average valuation percentile across equities, bonds and credit is the highest since 1900," they write, and it will produce two likely medium-term scenarios: "Slow pain" or "fast pain" as a correction creates a bear market.
Their analysis starts from the perspective of a "60/40" portfolio, meaning an investment that is 60% in the S&P 500 Index and 40% in US government bonds — a typical blend you'd see in any private pension mutual fund or 401(k) plan. It's exactly the type of investment you are likely to be relying on to retire, in other words. Bonds are usually used as a hedge against stocks because they often hold their value when shares tumble.

"The current valuation percentile is most comparable to the late 20s, which ended in the ‘Great Depression’"

But that extended runup since 2009 — nearly nine years with a correction — has created a scenario last seen right before the Great Depression in the early 20th Century, the Goldman team says:
"The favourable macro backdrop has boosted returns across assets, driving a ‘bull market in everything’, despite and because there has been little inflation in the real economy. But as a result, valuations across assets are expensive vs. history, which reduces the potential for returns and diversification ... And elevated valuations increase the risk of drawdowns for the simple reason that there is less buffer to absorb shocks. The average valuation percentile across equity, bonds and credit in the US is 90%, an all-time high. While equities and credit were more expensive in the Tech Bubble, bonds were comparably attractive at the time. The current valuation percentile is most comparable to the late 20s, which ended in the ‘Great Depression.’"
Here is the historical perspective:
historical bull markets   goldman sachsGoldman Sachs
Get the latest Goldman Sachs stock price here.

728 X 90

336 x 280

300 X 250

320 X 100

300 X600